Grown Rogue Industries

Grown Rogue International earns an Underweight rating, with a composite score in the mid-30s and low conviction. Regulatory performance is the strongest pillar, scoring in the high 40s as an absence of enforcement hits and a moderate jurisdiction posture offset weak filing cadence. The market pillar sits at 40 despite unavailable institutional pricing, limiting confirmation from trading signals. Editorial support remains subdued at 30, reflecting no recent newsroom or brief coverage. Fundamentals provide the largest drag at 22, driven by contracting sales, deeply negative operating profitability, a small market-cap tier, and limited cash-runway support. The resulting profile lacks the operating and market evidence required for a stronger band.

Licensed fundamentals data show year-over-year revenue contraction of 19.5%, while gross margin stands near 25.5%. That gross profitability fails to translate below the line: operating margin is negative by more than 119%, EBITDA records a loss of approximately $71.9 million, and net income records a loss of about $225.5 million. The cash-burn ratio of roughly 3.6 reinforces the stretched financial condition, and positive operating leverage remains absent. Primary regulatory filings show no event during the latest 90-day window and only one during the 180-day window, with the latest filing dated mid-June 2026. The cadence subscore of 25 materially trails the 80 enforcement subscore, leaving regulatory strength dependent more on the lack of enforcement actions than on frequent disclosure. Institutional pricing feeds provide no available quote, while CIN newsroom coverage contains no recent hits.

The clearest rerating catalyst sits within the regulatory pillar, already the company’s strongest contributor. More frequent primary regulatory filings would lift transparency, strengthen the weakest component inside that pillar, and provide fresher evidence on revenue stabilization, margin progression, and cash consumption. That improvement would also enable institutional pricing feeds and CIN newsroom coverage to assess developments against current disclosures rather than sparse updates. The single most important signal to watch is a sustained acceleration in primary regulatory filing cadence.